Cite
MLA Citation
Mahesh Swaminathan et al.. “A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure.” Leukemia & lymphoma, vol. 60, no. 9, 2019, pp. 2207–2213. http://access.bl.uk/ark:/81055/vdc_100132211835.0x000039